Ipilimumab in combination with nivolumab for the treatment of renal cell carcinoma
Author:
Affiliation:
1. Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
2. Biologic Therapy and Cutaneous Oncology Programs, Beth Israel Deaconess Medical Center, Boston, MA, USA
Funder
NIH Clinical Center
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14712598.2018.1513485
Reference74 articles.
1. International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
2. Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries
3. About Kidney Cancer. Atlanta, GA: american cancer society. [Cited 2018 Jul 31]: https://www.cancer.org/content/dam/CRC/PDF/Public/8659.00.pdf.
4. Cancer statistics, 2017
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Polypeptides-Based Nanocarriers in Tumor Therapy;Pharmaceutics;2024-09-10
2. Targeted nanomedicine modulating intercellular communications to arrest renal cell carcinoma progression;Journal of Drug Delivery Science and Technology;2024-09
3. An Overview of Immune Checkpoint Inhibitor Toxicities in Bladder Cancer;Toxicology Reports;2024-09
4. Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy;Journal of Translational Medicine;2024-08-09
5. ELISA assay for the quantification of ipilimumab in human serum, plasma, milk, and cerebrospinal fluid;Journal of Pharmaceutical and Biomedical Analysis;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3